West Oak Capital LLC Has $2.42 Million Position in The Procter & Gamble Company (NYSE:PG)

West Oak Capital LLC decreased its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 3.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 16,047 shares of the company’s stock after selling 505 shares during the quarter. Procter & Gamble makes up approximately 1.1% of West Oak Capital LLC’s investment portfolio, making the stock its 23rd biggest position. West Oak Capital LLC’s holdings in Procter & Gamble were worth $2,417,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the company. Procyon Advisors LLC grew its position in shares of Procter & Gamble by 15.8% during the 4th quarter. Procyon Advisors LLC now owns 63,055 shares of the company’s stock worth $9,240,000 after buying an additional 8,587 shares during the period. Shotwell Rutter Baer Inc bought a new stake in shares of Procter & Gamble during the 4th quarter valued at $219,000. Planned Solutions Inc. acquired a new position in shares of Procter & Gamble in the 4th quarter valued at $574,000. Highland Capital Management LLC boosted its position in shares of Procter & Gamble by 2.0% in the 4th quarter. Highland Capital Management LLC now owns 114,770 shares of the company’s stock worth $16,818,000 after purchasing an additional 2,285 shares during the last quarter. Finally, Columbia Trust Co 01012016 grew its stake in shares of Procter & Gamble by 36.8% during the fourth quarter. Columbia Trust Co 01012016 now owns 15,734 shares of the company’s stock worth $2,306,000 after purchasing an additional 4,236 shares during the period. 65.77% of the stock is currently owned by institutional investors.

Insider Activity

In other Procter & Gamble news, insider Marc S. Pritchard sold 101,704 shares of the company’s stock in a transaction on Wednesday, January 24th. The shares were sold at an average price of $153.57, for a total transaction of $15,618,683.28. Following the sale, the insider now owns 163,428 shares of the company’s stock, valued at $25,097,637.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, insider Marc S. Pritchard sold 101,704 shares of the firm’s stock in a transaction that occurred on Wednesday, January 24th. The shares were sold at an average price of $153.57, for a total transaction of $15,618,683.28. Following the completion of the sale, the insider now owns 163,428 shares of the company’s stock, valued at approximately $25,097,637.96. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the transaction, the chief executive officer now owns 4,859 shares in the company, valued at approximately $768,256.49. The disclosure for this sale can be found here. In the last three months, insiders have sold 279,063 shares of company stock valued at $43,187,745. 0.17% of the stock is currently owned by insiders.

Procter & Gamble Trading Down 0.1 %

NYSE:PG traded down $0.17 during mid-day trading on Thursday, hitting $162.44. 2,061,917 shares of the company’s stock were exchanged, compared to its average volume of 6,821,290. The firm has a market capitalization of $382.22 billion, a P/E ratio of 27.18, a PEG ratio of 3.28 and a beta of 0.44. The company has a 50 day simple moving average of $158.17 and a 200-day simple moving average of $152.09. The company has a current ratio of 0.64, a quick ratio of 0.44 and a debt-to-equity ratio of 0.48. The Procter & Gamble Company has a fifty-two week low of $141.45 and a fifty-two week high of $163.14.

Procter & Gamble (NYSE:PGGet Free Report) last announced its earnings results on Tuesday, January 23rd. The company reported $1.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.70 by $0.14. Procter & Gamble had a return on equity of 34.04% and a net margin of 17.60%. The business had revenue of $21.44 billion during the quarter, compared to analyst estimates of $21.48 billion. During the same period last year, the company earned $1.59 EPS. Procter & Gamble’s revenue for the quarter was up 3.2% compared to the same quarter last year. As a group, research analysts expect that The Procter & Gamble Company will post 6.45 earnings per share for the current year.

Procter & Gamble Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Friday, January 19th were issued a dividend of $0.9407 per share. The ex-dividend date was Thursday, January 18th. This represents a $3.76 annualized dividend and a yield of 2.32%. Procter & Gamble’s payout ratio is 62.98%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. The Goldman Sachs Group began coverage on Procter & Gamble in a research note on Friday, March 1st. They issued a “neutral” rating and a $168.00 target price on the stock. Truist Financial upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and increased their price target for the company from $160.00 to $175.00 in a research report on Monday, March 11th. Barclays lifted their price target on shares of Procter & Gamble from $160.00 to $165.00 and gave the stock an “overweight” rating in a research report on Thursday, January 25th. Royal Bank of Canada raised their price objective on Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a research note on Wednesday, January 24th. Finally, Wells Fargo & Company boosted their target price on Procter & Gamble from $162.00 to $170.00 and gave the company an “overweight” rating in a research note on Wednesday, January 24th. Seven equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $168.41.

View Our Latest Stock Analysis on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.